# Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

> **NCT02744755** · PHASE3 · COMPLETED · sponsor: **Sandoz** · enrollment: 353 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Adalimumab - GP2017
- **BIOLOGICAL:** Adalimumab - US licensed Humira

## Key facts

- **NCT ID:** NCT02744755
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-31
- **Primary completion:** 2017-01-31
- **Final completion:** 2017-09-26
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2018-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744755, "Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02744755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*